Jasper Therapeutics, Inc. fell 18.3% on Friday, November 20, 2026, on 11,716 shares. No headline about JSPR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Jasper Therapeutics, Inc. (JSPR:NASDAQ) closed at $8.69 on November 20, 2026, down 18.25% on the day. The stock trades 88.0% below its 52-week high of $72.60 and 2.6% above its 52-week low of $8.47. Over the past year, it lost 83.2%. Jasper Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 20, 2025, JSPR closed higher on 115 days (46%). Its best day was June 29, 2026 (+23.17%) and its worst was June 1, 2026 (-35.59%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 2 times.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Find more stocks like JSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.